CryoCell International Inc (CCEL)
CryoCell International Inc. is a common stock listing on the NYSE for a healthcare company focused on cord blood and cord tissue cryopreservation services in the United States. The company provides cellular processing and cryogenic storage for families, with services centered on collecting and preserving umbilical cord blood and tissue stem cells. It also processes and stores umbilical cord blood stem cells for public use. In addition, CryoCell manufactures PrepaCyte CB processing system units and provides cold storage services to third-party pharmaceutical companies and medical institutions. The company markets its preservation services directly to expectant parents and through healthcare professionals such as obstetricians, pediatricians, childbirth educators, and certified nurse-midwives. CryoCell International was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-CCEL
|
$4.57
|
-7.7% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
February 26, 2027
|
1.3x
|
39.91 M
|
44.498 M
|
17.7%
|
51.1%
|
-0.1
|
0.0%
|
-239.1%
|
